Detalhe da pesquisa
1.
Application of a Machine Learning Algorithm to Develop and Validate a Prediction Model for Ambulatory Non-Arrivals.
J Gen Intern Med;
38(10): 2298-2307, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36757667
2.
Use of TIMP-2 and IGFBP-7 for prediction of postoperative acute kidney injury after cardiac surgery.
Clin Nephrol;
98(6): 288-295, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36331021
3.
An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients.
Am J Transplant;
21(7): 2522-2531, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33443778
4.
Gastrointestinal bleeding in hospitalized COVID-19 patients: a propensity score matched cohort study.
J Intern Med;
289(6): 887-894, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33341978
5.
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.
Am J Kidney Dis;
77(2): 204-215.e1, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32961245
6.
Examination of Post-discharge Follow-up Appointment Status and 30-Day Readmission.
J Gen Intern Med;
36(5): 1214-1221, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33469750
7.
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19.
J Thromb Thrombolysis;
51(4): 897-901, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33665766
8.
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
J Thromb Thrombolysis;
52(4): 1032-1035, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34146235
9.
A Machine Learning Prediction Model of Respiratory Failure Within 48 Hours of Patient Admission for COVID-19: Model Development and Validation.
J Med Internet Res;
23(2): e24246, 2021 02 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33476281
10.
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.
Kidney Int;
98(6): 1530-1539, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32810523
11.
Acute kidney injury in patients hospitalized with COVID-19.
Kidney Int;
98(1): 209-218, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32416116
12.
COVID-19 in kidney transplant recipients.
Am J Transplant;
20(7): 1819-1825, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32351040
13.
COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case Series.
Am J Nephrol;
51(8): 669-674, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32731215
14.
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
JAMA;
323(20): 2052-2059, 2020 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32320003
15.
Wide intra- and inter-racial variation of end-stage kidney disease risk and transplant rate in pre-emptively listed kidney transplant candidates.
Clin Nephrol;
100(3): 140-142, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37366556
16.
Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection.
Am J Kidney Dis;
79(4): 480-482, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35032591
17.
Serum potassium laboratory reference ranges influence provider treatment behaviors for hyperkalemia.
Nephrol Dial Transplant;
36(3): 563-565, 2021 02 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33313863
18.
Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-19.
Nephrol Dial Transplant;
36(6): 1135-1138, 2021 05 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33724428
19.
The authors reply.
Kidney Int;
98(5): 1348-1349, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33126980
20.
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.
Am J Kidney Dis;
76(3): 303-305, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32479920